In recent months, the life sciences industry has seen the reemergence of contingent value rights, or CVRs, in public company acquisitions as a way to bridge a valuation gap between buyers and sellers. Recent public deals with CVRs include AstraZeneca’s acquisition of CinCor Pharma completed…
Source: corpgov.law.harvard.edu – Read more
Cybersecurity Vulnerabilities and Investment Risk in Small-Cap Tech Firms: Evaluating Wytec International’s Cyber Incident as a Warning Signal for the Sector – AInvest
Cybersecurity Vulnerabilities and Investment Risk in Small-Cap Tech Firms: Evaluating Wytec International’s Cyber Incident as a Warning Signal for the Sector AInvest
![Doctors reclaiming their humanity in a broken system [PODCAST]](https://i3.wp.com/kevinmd.com/wp-content/uploads/Design-2-scaled.jpg?w=0&resize=0,0&ssl=1 "Doctors reclaiming their humanity in a broken system [PODCAST]")